Latest news
FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1 - Managed Healthcare ExecutiveManaged Healthcare Executive · Fri, 07 Aug 2026 20:06:51 GMTScientists Identify the Brain Cells That Help Keep Us Motivated - ZME ScienceZME Science · Fri, 07 Aug 2026 11:52:40 GMTFDA Approves Oveporexton, First Orexin Receptor Agonist for Narcolepsy Type 1 - Patient Care OnlinePatient Care Online · Fri, 07 Aug 2026 06:16:23 GMTFavorable Phase 1 Data for Orexin-2 Agonist BP-205, Broader Pipeline Progress Headline Harmony's Q2 Update - NeurologyLiveNeurologyLive · Thu, 06 Aug 2026 23:10:51 GMTFDA Approves First-in-Class Narcolepsy Drug - MedPage TodayMedPage Today · Thu, 06 Aug 2026 20:46:04 GMTThe Race to Come Up With the Next Big Sleep Drug - WSJWSJ · Thu, 06 Aug 2026 18:30:00 GMTTakeda approval ushers in new wave of sleep drugs - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 16:10:45 GMTTakeda wins U.S. FDA approval for narcolepsy drug ORZEYFUL - International Business TimesInternational Business Times · Thu, 06 Aug 2026 15:36:29 GMT